A paying telehealth patient costs roughly $90 to $250 to acquire through paid media in 2026, and the range is driven by vertical: Rx skincare and hair loss sit near the bottom, hormone and TRT in the middle, and GLP-1 weight loss and mental health at the top. A paying patient is one who completes an intake and starts a plan, not a raw lead or free-trial signup, which runs far cheaper and converts inconsistently. These are agency averages across active DTC telehealth accounts, not guarantees.
This piece breaks down telehealth customer acquisition cost by vertical and then makes the more important argument: CAC on its own tells you almost nothing. Telehealth is a subscription business, so the number that decides whether an account is profitable is CAC measured against patient lifetime value and payback period, not the cost of the first order. A $200 CAC is excellent against a $1,600 LTV and a serious problem against a $400 one. Here is what a paying telehealth patient costs by vertical, why the ranges differ, and the LTV and payback math you should actually budget from.
- A paying telehealth patient costs roughly $90 to $250 to acquire through paid media in 2026, varying by vertical: Rx skincare and hair sit at the low end, GLP-1 weight loss and mental health at the top.
- CAC alone is the wrong number to budget from. The unit that decides profitability is CAC measured against patient LTV ($600 to $2,000) and payback period, targeted under 3 months.
- A healthy DTC telehealth account runs a 3:1 or better LTV-to-CAC ratio. Below roughly 3:1, the model does not fund its own growth.
- GLP-1 weight loss carries the highest CAC because ad-platform policy restricts branded weight-loss targeting and most before-and-after imagery, which narrows the audience and raises cost.
- HIPAA-compliant server-side tracking changes the CAC you actually see, because client-side pixels blocked for compliance and privacy under-report conversions and inflate apparent CAC. All figures are agency averages, not guarantees.
What does it cost to acquire a paying telehealth patient?
A paying telehealth patient costs $90 to $250 to acquire through paid media, measured across active DTC telehealth accounts as the cost of a patient who completes intake and starts a plan. The spread is almost entirely explained by vertical. Rx skincare and hair loss acquire cheapest because intent is high, the price of entry is low, and ad-platform policy is relatively permissive. Hormone and TRT sit in the middle. GLP-1 weight loss and mental health cost the most because demand is high but ad policy is restrictive and the audience is harder to reach compliantly. The table below shows typical CAC, patient LTV, and the resulting LTV-to-CAC ratio by vertical. These are agency averages, not guarantees, and any agency quoting a single flat CAC without asking which vertical you are in is quoting a number it cannot defend.
| Vertical | Typical CAC | Typical patient LTV | LTV : CAC | Why |
|---|---|---|---|---|
| Rx skincare (tretinoin) | $80-140 | $600-1,000 | 5-9x | High intent, low ticket, permissive ad policy |
| Hair (finasteride/minoxidil) | $90-150 | $600-1,100 | 5-8x | Low-friction decision, sticky refills |
| Hormone / TRT | $120-200 | $1,200-2,000 | 6-10x | Long retention, high LTV offsets CAC |
| GLP-1 weight loss | $150-250 | $900-1,600 | 3-6x | Restricted ad policy narrows targeting |
| Mental health / behavioral | $150-250 | $900-1,800 | 4-8x | High value, heaviest compliance load |
Why does CAC vary so much by telehealth vertical?
Telehealth CAC varies by vertical because three things differ across conditions: how restrictive the ad platforms are, how fast the patient decides, and how much the audience has to be narrowed to reach compliantly. Rx skincare and hair loss are low-friction, low-price decisions with relatively permissive ad policy, so a patient moves from click to intake in days and reach stays broad and cheap. GLP-1 weight loss faces the opposite conditions: Meta rejects branded pharmaceutical weight-loss terms and most before-and-after weight-loss imagery, which forces condition-education creative and narrower targeting, and that raises the cost to reach a paying patient. Mental health carries the heaviest compliance load and the most sensitive targeting rules. The vertical, not the ad account, sets most of the CAC range, which is why cross-vertical CAC benchmarks are close to meaningless. These are agency averages, not guarantees.
Why is CAC the wrong number to budget from?
CAC is the wrong number to budget from because telehealth is a subscription business, and the first order is only the entry point to a recurring relationship. The number that decides profitability is CAC measured against patient lifetime value and payback period. A telehealth patient LTV runs $600 to $2,000 depending on vertical and retention, so a $180 CAC that looks expensive against a single $99 first order is comfortable against a $1,400 lifetime value. Budgeting from first-order revenue or first-order return on ad spend systematically understates what a patient is worth and starves acquisition of budget it should be spending. The correct unit is the cost to acquire a patient set against the revenue that patient produces across the subscription tail, and the payback period that connects the two.
- A paying patient costs $90 to $250 depending on vertical
- Patient LTV runs $600 to $2,000 across telehealth verticals
- Payback period, target under 3 months, is the metric that ties CAC to LTV
- First-order ROAS understates patient value and under-funds acquisition
What LTV-to-CAC ratio should a telehealth brand target?
A DTC telehealth brand should target a lifetime-value-to-CAC ratio of 3:1 or better, meaning each paying patient returns at least three dollars of lifetime value for every dollar spent to acquire them. Below roughly 3:1, the model does not generate enough margin to fund growth, cover overhead, and absorb churn at the same time. Above 5:1 in a growth-stage brand often signals underspending, where the account is leaving profitable volume on the table by not scaling. The other half of the ratio is payback period: a strong telehealth account recovers CAC in under 3 months, which keeps cash cycling fast enough to reinvest. ClinicAds builds telehealth accounts toward a 3:1-or-better LTV-to-CAC ratio and a sub-3-month payback, and treats churn reduction as part of the same equation, because a small improvement in retention moves LTV and the ratio more than a comparable cut to CAC. These are agency averages, not guarantees.
Why does GLP-1 weight loss cost the most to acquire?
GLP-1 weight loss carries the highest telehealth CAC because ad-platform policy, not demand, is the binding constraint. Demand for semaglutide and tirzepatide is among the strongest in telehealth, but Meta rejects branded pharmaceutical weight-loss terms and the majority of before-and-after weight-loss imagery, and Google restricts prescription-drug and weight-loss advertising to policy-compliant landing paths, often requiring LegitScript certification. Those rules force GLP-1 brands to run condition-education and outcome-framed creative rather than the direct product-and-result ads that convert cheapest, and they narrow the audiences that can be targeted. The result is a $150 to $250 CAC where an unrestricted category might run half that. The brands that keep GLP-1 CAC in the lower part of that band do it with compliant creative kept in rotation so a single policy flag never freezes the account and costs a week of spend. These are agency averages, not guarantees.
How does HIPAA-compliant tracking change your CAC number?
HIPAA-compliant server-side tracking changes the CAC you actually see, because the compliant way to track telehealth conversions is also the more accurate way. Client-side browser pixels miss a large and growing share of conversions after browser privacy changes, and in healthcare they carry a second problem: sending patient data through a standard Meta or Google pixel is the exact setup that produced the Cerebral and BetterHelp FTC actions. When a telehealth brand strips patient data client-side to stay compliant, it also blinds the ad platforms, which under-reports conversions and makes CAC look worse than it is while the algorithms optimize on bad data. Server-side tracking through the Conversions API, with hashed identifiers and PHI stripped before any data reaches an ad platform, restores the conversion signal compliantly. In practice that recovers attribution, lowers apparent CAC, and lets the platforms optimize toward paying patients instead of noise. ClinicAds treats compliant server-side tracking as acquisition infrastructure, not a legal checkbox, because it is both the safe path and the accurate one. These are agency averages, not guarantees.
What does it cost to acquire a paying telehealth patient?
$90 to $250 through paid media in 2026, measured as a patient who completes intake and starts a plan. Rx skincare and hair sit at the low end, GLP-1 weight loss and mental health at the top. Figures are agency averages, not guarantees.
Why is GLP-1 patient acquisition cost higher than other telehealth verticals?
Ad-platform policy, not demand, drives it. Meta rejects branded weight-loss terms and most before-and-after imagery and Google restricts weight-loss and Rx advertising, which forces condition-education creative and narrower targeting and raises CAC to $150 to $250.
What LTV-to-CAC ratio should a telehealth brand aim for?
3:1 or better, with CAC payback under 3 months. Below roughly 3:1 the model does not fund its own growth. Above 5:1 in a growth-stage brand often signals underspending rather than efficiency.
Should I budget telehealth ads from CAC or from payback period?
From payback period against LTV, not CAC alone. Telehealth is a subscription business, so a $180 CAC is comfortable against a $1,400 lifetime value. Budgeting from first-order revenue understates patient value and under-funds acquisition.
Does HIPAA-compliant tracking affect my reported CAC?
Yes. Compliant server-side tracking through the Conversions API recovers conversions that client-side pixels miss after privacy changes, which lowers apparent CAC and lets the ad platforms optimize toward paying patients instead of incomplete data.